Analysis: Balaji Amines Limited

What does Balaji Amines Limited do?

• Balaji Amines is a leading Indian chemical company specializing in aliphatic amines and specialty fine chemicals since 1988.
• Reduces India's import dependency on critical chemicals through indigenous manufacturing technology.
• Serves pharmaceuticals, agrochemicals, and electric vehicles, with operations across four units in Solapur and Hyderabad.

• Product portfolio: Amines, amine derivatives, specialty chemicals (e.g., DMC, DMf, NMP).
• Expanding into electronic-grade DMC and dmf for EV batteries, with new projects like DME and NMM.

Growth thesis

Balaji Amines produces amines, amine derivatives, and specialty chemicals for pharmaceuticals, agrochemicals, and industrial applications. Key segments include Dimethyl Ether (DME, 100,000 MT capacity pending PESO approvals), N-Methyl Morpholine (NMM, 5,000 TPA), Acetonitrile (ACN), and Balaji Specialty Chemicals (HCN, NaCN, EDTA). Growth hinges on DME utilization (30-40% in FY27, 80-90% by FY28), ACN expansion (60 tpd by FY27), and BSC’s INR750 cr specialty chemicals complex. EBITDA margins are guided to 22-23% in FY27 as new projects stabilize, but delays in PESO approvals, 20-25% battery chemical utilization, and 40-50% BSC capacity underutilization remain critical risks. Management’s track record shows consistent underperformance on timelines (DME delayed 12+ months) despite strong capex execution, requiring close monitoring of regulatory and customer adoption progress.

Why is Balaji Amines Limited stock rising?

• DME plant expected to be commissioned in Q1 FY27, targeting aerosol and commercial LPG replacement markets
• N-Methyl Morpholine (NMM) project of 5,000 TPA capacity expected to be commissioned during FY27
• Improved process-based Acetonitrile plant expected to be commissioned in Q2 FY27
• Balaji Specialty Chemicals INR750 crore phased expansion granted mega project status under Maharashtra PSI 2019
• Unit 1 brownfield EDA value-added products (DETA, TETA, PIP, AEEA, AEP) expected to be commissioned in H1 FY27

Research report

companyname: Balaji Amines Limited ticker: BALAMINES sector: Chemicals - Speciality Chemicals / Aliphatic Amines Balaji Amines is a pioneer in Indian aliphatic amines chemistry. Founded in 1988, the company builds and operates continuous-process chemical plants that convert basic raw materials like methanol and ammonia into a growing catalog of amines, amine derivatives, and specialty chemicals. What sets Balaji apart is its ability to develop indigenous manufacturing technology for products th...

Catalysts

capex, margin expansion

Growth guidance

FY27 volume growth guided at 25-30% and EBITDA margin of 22-23% driven by new project commissioning

Management consistency

mixed